¼¼°èÀÇ ÀüÀÚ ÀÓ»ó °á°ú Æò°¡ ¼Ö·ç¼Ç ½ÃÀå º¸°í¼­(2025³â)
Electronic Clinical Outcome Assessment Solutions Global Market Report 2025
»óǰÄÚµå : 1675213
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,156,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 8,898,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,640,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÀüÀÚ ÀÓ»ó °á°ú Æò°¡ ¼Ö·ç¼Ç ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³âµ¿¾È ¿¬Æò±Õ ¼ºÀå·ü(CAGR) 13.7%·Î 2029³â 32¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ¼ºÀå ¿äÀÎÀ¸·Î´Â ¿þ¾î·¯ºí ±â±â¿ÍÀÇ ÅëÇÕ, ºÐ»êÇü ¹× ÇÏÀ̺긮µå ÀÓ»ó½ÃÇè, ȯÀÚ Âü¿© Àü·«, º¸¾È ¹× ÄÄÇöóÀ̾𽺠´ëÃ¥, ¿ø°Ý ¸ð´ÏÅ͸µ, ÀÓ»ó½ÃÇè ±â°ü°úÀÇ ¿¬°è µîÀÌ ÀÖ½À´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ÀÓ»ó½ÃÇèÀÇ ÀΰøÁö´É, ÀÓ»ó½ÃÇèÀÇ µðÁöÅÐÈ­, ¸ð¹ÙÀÏ ±â¼úÀÇ ¹ßÀü, ¸®¾ó¿ùµå Áõ°ÅÀÇ ÅëÇÕ, ȯÀÚ º¸°í °á°ú(PRO)¿¡ ´ëÇÑ Á߿伺 µîÀÌ ÀÖ½À´Ï´Ù.

ÀüÀÚ ÀÓ»ó °á°ú Æò°¡ ¼Ö·ç¼Ç ½ÃÀåÀº ¿¬±¸°³¹ß Ȱµ¿ÀÌ È°¹ßÇØÁü¿¡ µû¶ó ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. R&D Ȱµ¿Àº »õ·Î¿î Á¦Ç° ¹× ¼­ºñ½º¸¦ Çõ½ÅÇÏ°í µµÀÔÇϱâ À§ÇØ ±â¾÷ÀÌ ¼öÇàÇÏ´Â ÀÌ´Ï¼ÅÆ¼ºê¸¦ Æ÷°ýÇÕ´Ï´Ù. ÀüÀÚ ÀÓ»ó °á°ú Æò°¡ ¼Ö·ç¼ÇÀº ÀÓ»ó½ÃÇèÀÇ °á°ú µ¥ÀÌÅ͸¦ ÀüÀÚÀûÀ¸·Î ȹµæÇÔÀ¸·Î½á ÀÌ·¯ÇÑ ³ë·Â¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÏ·Ê·Î, 2023³â 11¿ù ¹Ì±¹ Á¤ºÎ ±â°üÀÎ National Center for Science and Engineering Statistics(±¹¸³°úÇаøÇÐÅë°è¼¾ÅÍ)´Â 2022 ȸ°è¿¬µµ¿¡ Çмú ±â°üÀÌ ¿¬±¸°³¹ß¿¡ ÅõÀÚÇÑ ÃѾ×ÀÌ 978¾ï ´Þ·¯·Î 2021 ȸ°è¿¬µµ¿¡ ºñÇØ 80¾ï ´Þ·¯ Áõ°¡Çß´Ù°í ¹ßÇ¥Çß½À´Ï´Ù. 2021³â ȸ°è¿¬µµ ´ëºñ 80¾ï ´Þ·¯ Áõ°¡Çß´Ù°í º¸°íÇß½À´Ï´Ù. ¶ÇÇÑ ´ëÇÐÀÇ ¿¬±¸°³¹ß(R&:D)À» À§ÇÑ ³»ºÎ ÀÚ±ÝÀº 2021ȸ°è¿¬µµ¿¡ ºñÇØ 21¾ï ´Þ·¯ÀÇ ´«¿¡ ¶ç´Â Áõ°¡¸¦ º¸¿´À¸¸ç, ±â¾÷¿¡¼­ ´ëÇп¡ ´ëÇÑ R&:D ÀÚ±ÝÀº 5¾ï 8,700¸¸ ´Þ·¯ Áõ°¡¸¦ º¸¿´½À´Ï´Ù. ±× °á°ú, ¿¬±¸ °³¹ß Ȱµ¿ÀÇ ±ÞÁõÀº ÀüÀÚ ÀÓ»ó °á°ú Æò°¡ ¼Ö·ç¼Ç ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

ÀüÀÚ ÀÓ»ó °á°ú Æò°¡ ¼Ö·ç¼Ç ½ÃÀåÀÇ ¼ºÀå Àü¸ÁÀÇ ¹è°æ¿¡´Â ÀÓ»ó½ÃÇè Áõ°¡°¡ ÀÖ½À´Ï´Ù. ÀÓ»ó½ÃÇèÀº ÀÇ·á Ä¡·á, ¾à¹°, ±â±â, °³ÀÔÀÇ ¾ÈÀü¼º, À¯È¿¼º, ÀáÀçÀû ºÎÀÛ¿ëÀ» Æò°¡Çϱâ À§ÇØ »ç¶÷À» ´ë»óÀ¸·Î ¼öÇàµÇ´Â Á¶»ç ¿¬±¸ÀÔ´Ï´Ù. ÀüÀÚ ÀÓ»ó °á°ú Æò°¡(eCOA) ¼Ö·ç¼ÇÀº ȯÀÚ º¸°í °á°ú ¹× ±âŸ °ü·Ã µ¥ÀÌÅ͸¦ ¼öÁýÇÒ ¼ö ÀÖ´Â µðÁöÅÐ ¹æ½ÄÀ¸·Î ÇÕ¸®ÀûÀÎ Á¢±Ù ¹æ½ÄÀ» Á¦°øÇÔÀ¸·Î½á ÀÓ»ó½ÃÇè¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ µðÁöÅÐ ¹Ìµð¾î ȸ»ç Xtalks°¡ 2023³â 5¿ù¿¡ º¸°íÇÑ ¹Ù¿¡ µû¸£¸é, ClinicalTrials.gov¿¡ µî·ÏµÈ Àü ¼¼°è ÀÓ»ó½ÃÇè µî·Ï °Ç¼ö´Â 2023³â¿¡ 452,604°ÇÀ¸·Î 2021³â º¸°íµÈ 365,000°Ç À̻󿡼­ Å©°Ô Áõ°¡Çß½À´Ï´Ù. ¶ÇÇÑ, ÀÌ 452,604°ÇÀÇ ÀÓ»ó½ÃÇè Áß 64,838°ÇÀÌ Àû±ØÀûÀ¸·Î Âü°¡ÀÚ¸¦ ¸ðÁýÇϰí ÀÖ½À´Ï´Ù. µû¶ó¼­ ÀÓ»ó½ÃÇè ¼ö Áõ°¡´Â ÀüÀÚ ÀÓ»ó °á°ú Æò°¡ ¼Ö·ç¼Ç ½ÃÀå ¼ºÀåÀÇ Ã˸ÅÁ¦ ¿ªÇÒÀ» ÇÒ °ÍÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, Covid¿Í ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Electronic clinical outcome assessment involves capturing outcome data electronically in clinical trials, streamlining the collection of crucial data points for analysis.

The primary categories of products within electronic clinical outcome assessment (eCOA) solutions include web-based eCOA solutions, on-premise-based eCOA solutions, and cloud-platform-based eCOA solutions. Web-based eCOA solutions denote programs distributed over a network, commonly a corporate intranet or the internet, and accessible through a standard web browser. These solutions encompass various approaches such as patient-reported outcome (PRO), clinician-reported outcome (ClinRO), observer-reported outcome (ObsRO), and performance outcome (PerfO). They find application in hospitals or healthcare providers, contract research organizations (CROs), pharmaceutical and biotechnology firms, medical device companies, and other end users.

The electronic clinical outcome assessment solutions market research report is one of a series of new reports from The Business Research Company that provides electronic clinical outcome assessment solutions market statistics, including electronic clinical outcome assessment solutions industry global market size, regional shares, competitors with an electronic clinical outcome assessment solutions market share, detailed electronic clinical outcome assessment solutions market segments, market trends and opportunities, and any further data you may need to thrive in the electronic clinical outcome assessment solutions industry. This electronic clinical outcome assessment solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The electronic clinical outcome assessment solutions market size has grown rapidly in recent years. It will grow from $1.68 billion in 2024 to $1.94 billion in 2025 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to regulatory support, patient-centric approach, data quality and accuracy, cost efficiency and time savings, increasing global clinical trials.

The electronic clinical outcome assessment solutions market size is expected to see rapid growth in the next few years. It will grow to $3.25 billion in 2029 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to integration with wearable devices, decentralized and hybrid trials, patient engagement strategies, security and compliance measures, remote monitoring and site collaboration. Major trends in the forecast period include artificial intelligence in clinical trials, clinical trial digitization, advancements in mobile technology, real-world evidence integration, patient-reported outcomes (PROs) emphasis.

The electronic clinical outcome assessment solutions market is anticipated to experience growth due to an upswing in research and development activities. Research and development activities encompass the initiatives undertaken by companies to innovate and introduce new products and services. Electronic clinical outcome assessment solutions contribute to these endeavors by electronically capturing outcomes data in clinical trials. As an illustration, in November 2023, the National Center for Science and Engineering Statistics, a US-based government agency, reported that in the fiscal year 2022, academic institutions allocated a total of $97.8 billion to research and development, indicating an increase of $8.0 billion compared to fiscal year 2021. Furthermore, internal funding for Research and Development (R&D) at universities exhibited a notable rise of $2.1 billion compared to the fiscal year 2021, while R&D funding from businesses to universities saw a growth of $587 million. Consequently, the surge in research and development activities is a key driver for the electronic clinical outcome assessment solutions market.

The anticipated growth of the electronic clinical outcome assessment solutions market is attributed to the rising number of clinical trials. Clinical trials are research studies or investigations conducted on human subjects to assess the safety, efficacy, and potential side effects of medical treatments, drugs, devices, or interventions. Electronic Clinical Outcome Assessment (eCOA) solutions play a vital role in clinical trials by offering a digital and streamlined approach to collecting patient-reported outcomes and other relevant data. For instance, as reported by the US-based digital media company Xtalks in May 2023, the global registration count on ClinicalTrials.gov reached 452,604 clinical trials in 2023, marking a significant increase from the reported over 365,000 registered trials in 2021. Furthermore, among these 452,604 clinical trials, 64,838 are actively recruiting participants. Hence, the escalating number of clinical trials serves as a catalyst for the growth of the electronic clinical outcome assessment solutions market.

Technological advancements are a significant trend gaining traction in the electronic clinical outcome assessment solutions market. Major companies in this sector are focused on developing innovative platforms to strengthen their market position. For example, in May 2024, EDETEK, a U.S.-based technology company specializing in digital solutions for the clinical trial sector, announced the launch of CONFORM eClinical Version 5.1. This comprehensive platform is designed to enhance and streamline clinical trial management processes. The new version integrates a wide array of components that facilitate efficient clinical research, addressing the evolving needs of sponsors and stakeholders within the pharmaceutical industry.

Key players in the electronic clinical outcome assessment solutions market are focusing their efforts on the development of innovative solutions, notably eCOA toolkits. An eCOA (Electronic Clinical Outcome Assessment) toolkit is a collection of software tools and resources strategically designed to facilitate the implementation and management of electronic methods for gathering patient-reported outcomes and other critical clinical trial data. As an illustration, in December 2022, Suvoda, a US-based software company, unveiled its electronic clinical outcome assessments (eCOA) design toolkit. This toolkit is seamlessly integrated with Suvoda IRT and eConsent, addressing previous shortcomings that have impacted the field of eCOA. It features a specialized language and authoring tool specifically crafted for the creation of eCOA questionnaires.

In November 2022, Citeline, a leading provider of pharmaceutical intelligence solutions based in the U.S., merged with Norstella in a deal valued at approximately $5 billion. This merger aims to enhance patient outcomes by improving access to therapies, streamlining drug development processes, and providing innovative solutions tailored to the evolving needs of the pharmaceutical industry. Norstella is recognized as a global leader in pharmaceutical intelligence and consulting services, also based in the U.S.

Major companies operating in the electronic clinical outcome assessment solutions market include IQVIA Holdings Inc., Oracle Corporation, ERT Clinical, Dassault Systemes SE, OmniComm Systems Inc., Parexel International Corporation, Veeva Systems Inc., KUKDO CHEMICAL CO. LTD., Medidata Solutions Inc., Signant Health, Clario Inc., ArisGlobal LLC, Merge Healthcare Inc., YPrime LLC, eClinical Solutions LLC, CRF Bracket Company, Anju Software Inc., Castor EDC B.V., Kayentis, Mednet Solutions LLC, Clinical Ink Inc., Cloudbyz Inc., Climedo Health GmbH, ClinCapture Inc.

North America was the largest region in the electronic clinical outcome assessment solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the electronic clinical outcome assessment solutions market during the forecast period. The regions covered in the electronic clinical outcome assessment solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the electronic clinical outcome assessment solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The electronic clinical outcome assessment solutions market consists of sales of eCOA live, eCOA multimedia, eCOA rescue studies, and suicidal ideation. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Electronic Clinical Outcome Assessment Solutions Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on electronic clinical outcome assessment solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for electronic clinical outcome assessment solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The electronic clinical outcome assessment solutions market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Electronic Clinical Outcome Assessment Solutions Market Characteristics

3. Electronic Clinical Outcome Assessment Solutions Market Trends And Strategies

4. Electronic Clinical Outcome Assessment Solutions Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Electronic Clinical Outcome Assessment Solutions Growth Analysis And Strategic Analysis Framework

6. Electronic Clinical Outcome Assessment Solutions Market Segmentation

7. Electronic Clinical Outcome Assessment Solutions Market Regional And Country Analysis

8. Asia-Pacific Electronic Clinical Outcome Assessment Solutions Market

9. China Electronic Clinical Outcome Assessment Solutions Market

10. India Electronic Clinical Outcome Assessment Solutions Market

11. Japan Electronic Clinical Outcome Assessment Solutions Market

12. Australia Electronic Clinical Outcome Assessment Solutions Market

13. Indonesia Electronic Clinical Outcome Assessment Solutions Market

14. South Korea Electronic Clinical Outcome Assessment Solutions Market

15. Western Europe Electronic Clinical Outcome Assessment Solutions Market

16. UK Electronic Clinical Outcome Assessment Solutions Market

17. Germany Electronic Clinical Outcome Assessment Solutions Market

18. France Electronic Clinical Outcome Assessment Solutions Market

19. Italy Electronic Clinical Outcome Assessment Solutions Market

20. Spain Electronic Clinical Outcome Assessment Solutions Market

21. Eastern Europe Electronic Clinical Outcome Assessment Solutions Market

22. Russia Electronic Clinical Outcome Assessment Solutions Market

23. North America Electronic Clinical Outcome Assessment Solutions Market

24. USA Electronic Clinical Outcome Assessment Solutions Market

25. Canada Electronic Clinical Outcome Assessment Solutions Market

26. South America Electronic Clinical Outcome Assessment Solutions Market

27. Brazil Electronic Clinical Outcome Assessment Solutions Market

28. Middle East Electronic Clinical Outcome Assessment Solutions Market

29. Africa Electronic Clinical Outcome Assessment Solutions Market

30. Electronic Clinical Outcome Assessment Solutions Market Competitive Landscape And Company Profiles

31. Electronic Clinical Outcome Assessment Solutions Market Other Major And Innovative Companies

32. Global Electronic Clinical Outcome Assessment Solutions Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Electronic Clinical Outcome Assessment Solutions Market

34. Recent Developments In The Electronic Clinical Outcome Assessment Solutions Market

35. Electronic Clinical Outcome Assessment Solutions Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â